The Cooper Companies, Inc. reports developments for a global medical device business organized around CooperVision and CooperSurgical. CooperVision news centers on soft contact lenses, specialty lens designs, myopia management products such as MiSight® 1 day, MyDay® contact lenses, practitioner support, and sustainability initiatives tied to lens materials, packaging, manufacturing, and plastic footprint programs.
CooperCompanies news also covers quarterly financial results, conference participation, board appointments, and governance matters. CooperSurgical provides fertility and women’s healthcare products, while companywide updates describe operating performance, capital priorities, and corporate developments across its medical device portfolio.
CooperCompanies (NYSE: COO) plans to release its second quarter 2020 financial results on June 4, 2020, at 4:15 PM ET. A conference call will follow at 5:00 PM ET to discuss results and corporate developments. Investors can join via dial-in or a webcast available on the CooperCompanies website. A recording of the call will be accessible from June 4 at 8:00 PM ET until June 11, 2020. Cooper operates through CooperVision and CooperSurgical, focusing on vision care and women's health.